Hims & Hers (HIMS) Reports 3% Stock Decline After Q2 Loss

Hims & Hers Health (HIMS) stock declined 3% before trimming losses on August 11, 2026. The company reported a loss of $0.37 per share in Q2, down from a profit of $0.17 per share in the same period last year, with gross margins decreasing to 64% from 76%. This performance was affected by a one-time cost of $81 million, associated with the acquisition of Eucalyptus and restructuring due to changes in their weight-loss strategy. These financial results highlight the ongoing regulatory challenges and shifts in strategy, which are significant for investors tracking the company's performance.